Susceptibility of Streptococcus mutans and Streptococcus sobrinus to cell wall inhibitors and development of a novel selective medium for S. sobrinus.
Representative strains of Streptococcus mutans and Streptococcus sobrinus showed differences in susceptibility to members of the monobactam group of beta-lactam antibiotics: S. sobrinus was less sensitive than S. mutans. The minimum inhibitory concentrations of aztreonam (AZT) and carumonam, both of which belong to this group, were 2,000 microg/ml for S. sobrinus and 125 microg/ml for S. mutans. Further addition of fosfomycin, bacitracin and sodium chloride to Mitis Salivarius agar (MS) supplemented with AZT resulted in growth inhibition of S. mutans and oral streptococci other than S. sobrinus, and was therefore used as a selective medium for S. sobrinus (MS-SOB medium). The average growth recovery of laboratory and clinically isolated strains of S. sobrinus on MS-SOB medium was 74.1% compared to that on MS medium. Seventy-eight percent of clinical samples in which S. sobrinus was detected yielded pure growth of S. sobrinus on MS-SOB medium.
Hirasawa
M
M
Department of Microbiology, Nihon University School of Dentistry at Matsudo, Chiba, Japan. masahira@mascat.nihon-u.ac.jp
Takada
K
K
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology; D001398:Aztreonam / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D001414:Bacitracin / Q000008:administration & dosage / Q000494:pharmacology; D015169:Colony Count, Microbial; D003470:Culture Media / Q000737:chemistry; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination / Q000008:administration & dosage / Q000494:pharmacology; D005578:Fosfomycin / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D008826:Microbial Sensitivity Tests; D008997:Monobactams / Q000008:administration & dosage / Q000494:pharmacology*; D012965:Sodium Chloride; D013291:Streptococcus / Q000187:drug effects / Q000254:growth & development; D013295:Streptococcus mutans / Q000187:drug effects*; D016986:Streptococcus sobrinus / Q000145:classification / Q000187:drug effects* / Q000254:growth & development
D000900:Anti-Bacterial Agents; D003470:Culture Media; D008997:Monobactams; D001414:Bacitracin; D005578:Fosfomycin; D012965:Sodium Chloride; C044145:carumonam; D001398:Aztreonam